Low-dose Prothrombin Complex Concentrate for Warfarin-Associated Intracranial Hemorrhage with INR Less Than 2.0

被引:0
作者
Wesley R. Zemrak
Kathryn E. Smith
Stephen S. Rolfe
Teresa May
Robert L. Trowbridge
Timothy L. Hayes
Gene A. Grindlinger
David B. Seder
机构
[1] Maine Medical Center,Department of Pharmacy
[2] Maine Medical Center,Division of Neurocritical Care
[3] Maine Medical Center,Department of Medicine
[4] Maine Medical Center,Department of Pathology
[5] Maine Medical Center,Division of Surgical Critical Care
来源
Neurocritical Care | 2017年 / 27卷
关键词
Warfarin; Prothrombin complex concentrate; Intracranial hemorrhage; Reversal;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:334 / 340
页数:6
相关论文
共 50 条
  • [41] Prothrombin Complex Concentrate for Vitamin K Antagonist-Associated Intracranial Hemorrhage - Global Evidence and the Japanese Perspective -
    Yasaka, Masahiro
    Brainsky, Andres
    Toyoda, Kazunori
    CIRCULATION JOURNAL, 2017, 81 (11) : 1564 - +
  • [42] Use of low-dose prothrombin complex concentrate before lumbar punc
    Butler, Jared J.
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2015, 72 (03) : 203 - 205
  • [43] LOW-DOSE WARFARIN DECREASES COAGULABILITY WITHOUT AFFECTING PROTHROMBIN COMPLEX ACTIVITY
    HOLM, J
    BERNTORP, E
    CARLSSON, R
    ERHARDT, L
    JOURNAL OF INTERNAL MEDICINE, 1993, 234 (03) : 303 - 308
  • [44] A Low-Dose 4F-PCC Protocol for DOAC-Associated Intracranial Hemorrhage
    Berger, Karen
    Santibanez, Melissa
    Lin, Lina
    Lesch, Christine A.
    JOURNAL OF INTENSIVE CARE MEDICINE, 2020, 35 (11) : 1203 - 1208
  • [45] Inactivated Four-Factor Prothrombin Complex Concentrate Dosing Practices for Reversal of Warfarin-Related Intracranial Hemorrhage
    Denise H. Rhoney
    Mary La
    Molly Merz
    Aaron Cook
    Kent A. Owusu
    Christina Roels
    Joe Blunck
    Justin Shewmaker
    Kiranpal S. Sangha
    Salia Farrokh
    John Lewin
    Kathleen W. Chester
    Theresea Human
    Kathleen Bledsoe
    Kristy Greene
    Melissa Levesque
    Jody C. Rocker
    Gary Davis
    Ron Neyens
    Timothy F. Lassiter
    Sarah M. Adriance
    Neurocritical Care, 2021, 35 : 130 - 138
  • [46] Inactivated Four-Factor Prothrombin Complex Concentrate Dosing Practices for Reversal of Warfarin-Related Intracranial Hemorrhage
    Rhoney, Denise H.
    La, Mary
    Merz, Molly
    Cook, Aaron
    Owusu, Kent A.
    Roels, Christina
    Blunck, Joe
    Shewmaker, Justin
    Sangha, Kiranpal S.
    Farrokh, Salia
    Lewin, John
    Chester, Kathleen W.
    Human, Theresea
    Bledsoe, Kathleen
    Greene, Kristy
    Levesque, Melissa
    Rocker, Jody C.
    Davis, Gary
    Neyens, Ron
    Lassiter, Timothy F.
    Adriance, Sarah M.
    NEUROCRITICAL CARE, 2021, 35 (01) : 130 - 138
  • [47] Efficacy and safety of prothrombin complex concentrate for vitamin K antagonist-associated intracranial hemorrhage: a systematic review and meta-analysis
    Pan, Rui
    Cheng, Jinping
    Lai, Kelin
    Huang, Qing
    Wu, Hui
    Tang, Yamei
    NEUROLOGICAL SCIENCES, 2019, 40 (04) : 813 - 827
  • [48] Recombinant Activated Coagulation Factor VII and Prothrombin Complex Concentrates Are Equally Effective in Reducing Hematoma Volume in Experimental Warfarin-Associated Intracerebral Hemorrhage
    Schlunk, Frieder
    Van Cott, Elizabeth M.
    Hayakawa, Kazuhide
    Pfeilschifter, Waltraud
    Lo, Eng H.
    Foerch, Christian
    STROKE, 2012, 43 (01) : 246 - 249
  • [49] Adjusted versus actual body weight dosing of 4-factor prothrombin complex concentrate in obese patients with warfarin-associated major bleeding
    Smetana, Keaton S.
    Ziemba, Rachel
    May, Casey C.
    Erdman, Michael J.
    Van Matre, Edward T.
    Jones, G. Morgan
    JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2019, 47 (03) : 369 - 374
  • [50] The effectiveness and safety of fixed low-dose prothrombin complex concentrates in patients requiring urgent reversal of warfarin
    Varga, Cindy
    Al-Touri, Sultan
    Papadoukakis, Stella
    Caplan, Stephen
    Kahn, Susan
    Blostein, Mark
    TRANSFUSION, 2013, 53 (07) : 1451 - 1458